Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.9200 (-1%) ($7.9200 - $8.0000) on Mon. May. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 62 | Latest Price | $7.9200(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.9% a day on average for past five trading days. | Weekly Trend | ANPC advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(10%) XLB(10%) LIT(9%) IPO(8%) FXI(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.67% in a week (0% probabilities). SHY(-16%) XBI(-6%) XLU(-5%) IGOV(-5%) IBB(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $7.99(-0.88%) | 10 Day Moving Average | $7.87(0.64%) | 20 Day Moving Average | $7.81(1.41%) | To recent high | -24.4% | To recent low | 12% | Market Cap | $68m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |